Similar articles for PMID: 34503964

Year	Number of Results
1998	1
2005	1
2007	1
2010	2
2011	1
2012	3
2013	3
2014	1
2016	3
2017	10
2018	12
2019	12
2020	25
2021	29
2022	47
2023	23
2024	0

1

¹⁸F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study.

Nienhuis PH, Antunes IF, Glaudemans AWJM, Jalving M, Leung D, Noordzij W, Slart RHJA, de Vries EFJ, Hospers GAP. Nienhuis PH, et al. J Nucl Med. 2022 Jun;63(6):899-905. doi: 10.2967/jnumed.121.262368. Epub 2021 Sep 9. J Nucl Med. 2022. PMID: 34503964 Free PMC article.

2

⁸⁹Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.

Verhoeff SR, van de Donk PP, Aarntzen EHJG, Oosting SF, Brouwers AH, Miedema IHC, Voortman J, Menke-van der Houven van Oordt WC, Boellaard R, Vriens D, Slingerland M, Hermsen R, Grunsven IVE, Heskamp S, van Herpen CML. Verhoeff SR, et al. J Nucl Med. 2022 Oct;63(10):1523-1530. doi: 10.2967/jnumed.121.263470. Epub 2022 May 5. J Nucl Med. 2022. PMID: 35512998 Free PMC article.

3

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.

van de Donk PP, Wind TT, Hooiveld-Noeken JS, van der Veen EL, Glaudemans AWJM, Diepstra A, Jalving M, de Vries EGE, de Vries EFJ, Hospers GAP. van de Donk PP, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4369-4376. doi: 10.1007/s00259-021-05407-y. Epub 2021 Jun 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 34076745 Free PMC article.

4

Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo¹⁸F-FDG-PET.

Schwenck J, Schörg B, Fiz F, Sonanini D, Forschner A, Eigentler T, Weide B, Martella M, Gonzalez-Menendez I, Campi C, Sambuceti G, Seith F, Quintanilla-Martinez L, Garbe C, Pfannenberg C, Röcken M, la Fougere C, Pichler BJ, Kneilling M. Schwenck J, et al. Theranostics. 2020 Jan 1;10(2):925-937. doi: 10.7150/thno.35989. eCollection 2020. Theranostics. 2020. PMID: 31903160 Free PMC article.

5

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

6

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study.

Hribernik N, Huff DT, Studen A, Zevnik K, Klaneček Ž, Emamekhoo H, Škalic K, Jeraj R, Reberšek M. Hribernik N, et al. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1857-1869. doi: 10.1007/s00259-021-05650-3. Epub 2021 Dec 27. Eur J Nucl Med Mol Imaging. 2022. PMID: 34958422 Free PMC article.

7

The Value of ¹⁸F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression.

Vekens K, Everaert H, Neyns B, Ilsen B, Decoster L. Vekens K, et al. Clin Lung Cancer. 2021 Sep;22(5):432-440. doi: 10.1016/j.cllc.2021.03.001. Epub 2021 Mar 20. Clin Lung Cancer. 2021. PMID: 33879398

8

Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors.

Annovazzi A, Vari S, Giannarelli D, Pasqualoni R, Sciuto R, Carpano S, Cognetti F, Ferraresi V. Annovazzi A, et al. Clin Nucl Med. 2020 Mar;45(3):187-194. doi: 10.1097/RLU.0000000000002921. Clin Nucl Med. 2020. PMID: 31977479

9

¹⁸F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.

Ito K, Teng R, Schöder H, Humm JL, Ni A, Michaud L, Nakajima R, Yamashita R, Wolchok JD, Weber WA. Ito K, et al. J Nucl Med. 2019 Mar;60(3):335-341. doi: 10.2967/jnumed.118.213652. Epub 2018 Nov 9. J Nucl Med. 2019. PMID: 30413661 Free PMC article.

10

PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer.

Smit J, Borm FJ, Niemeijer AN, Huisman MC, Hoekstra OS, Boellaard R, Oprea-Lager DE, Vugts DJ, van Dongen GAMS, de Wit-van der Veen BJ, Thunnissen E, Smit EF, de Langen AJ. Smit J, et al. J Nucl Med. 2022 May;63(5):686-693. doi: 10.2967/jnumed.121.262473. Epub 2021 Aug 12. J Nucl Med. 2022. PMID: 34385342 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year